Status:
COMPLETED
A Brief Digital Screening Tool to Address Tobacco and E-cigarette Use in Pediatric Medical Care
Lead Sponsor:
St. Justine's Hospital
Conditions:
Tobacco Use
Tobacco Cessation
Eligibility:
All Genders
14+ years
Phase:
NA
Brief Summary
Tobacco use is the single greatest preventable cause of morbidity and mortality in Canada, accounting for 48,000 deaths and $16.2 billion annually in attributable health-related costs. Parents who smo...
Detailed Description
Background: Tobacco use is the single greatest preventable cause of morbidity and mortality in Canada, accounting for 48,000 deaths and $16.2 billion in attributable health-related costs annually. Twe...
Eligibility Criteria
Inclusion
- Parents or legal guardians of children 0-17 years old and who smoke or use nicotine vaping products. "User" will be defined as those who answer "Yes" to the screening questions:
- "Have you smoked a single cigarette, even a puff, in the past 7 days?" (smoking);
- "Have you used an e-cigarette or vaping device containing nicotine, even a puff, in the past 7 days? (vaping).
- For CEASE-A, adolescent patients aged 14-17 years who smoke or use nicotine vaping products will be considered. "Adolescent User" will be defined by those who answer "Yes" to the same screening question as parents.
- Parents will be eligible if 1) they are at least 18 years old, 2) their child is 0-17 years of age, 3) are attending a regular scheduled medical appointment, and 4) are sufficiently proficient in either French or English (able to read and answer a written questionnaire).
- Adolescents will be eligible if they are 14-17 years-old, meet criteria 3) and 4) above, and have provided informed consent (in Québec, adolescents aged 14 years can provide consent). Adolescents whose parent(s) (if present) are not agreeable to their participation will be excluded.
Exclusion
- Families presenting to the clinic without a scheduled medical appointment will be excluded. There will be no other exclusion criteria.
Key Trial Info
Start Date :
February 22 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 2024
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT05366790
Start Date
February 22 2023
End Date
June 10 2024
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Clinic of the CHU Sainte-Justine
Montreal, Quebec, Canada, H3T 1C5